Skip to main content
. 2008 Oct 1;10(5):423–430. doi: 10.1016/j.jfms.2008.01.008

Table 2.

MDA and GPx concentrations in the supplemented FIV-infected and uninfected control groups pre- and post-supplementation

Group MDA (μmol/l) GPx (U/l)
Day 0 Day 30 Day 0 Day 30
Suppl FIV-inf 36.8 33.5 96,217 119,800
Uninfected control 30.3 32.5 109,500 92,167

No significant differences found between suppl (supplemented). FIV-inf (infected) and uninfected control groups.